{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:42:01Z","timestamp":1791297721456,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glucose-regulated protein 78 (GRP78) is a member of the heat-shock protein 70 family. We evaluated the expression of GRP78 using tissue microarray-based immunohistochemistry in tumor tissues and adjacent nontumor tissues from 180 pancreatic ductal adenocarcinoma (PDAC) patients. The associations between the expression levels of GRP78, clinicopathological factors and overall survival were evaluated. The results showed that the expression of GRP78 was significantly higher in PDAC cells than in normal pancreatic duct cells within adjacent nontumor tissues (p\u2009&lt;\u20090.05). The increased expression of GRP78 in the tumor tissues was significantly correlated with a higher T-stage (p\u2009&lt;\u20090.05) and a shorter overall survival (OS, p\u2009&lt;\u20090.05). In an <jats:italic>in vitro<\/jats:italic> study, the regulation of GRP78 in the PDAC cell lines affected the proliferation, migration and invasion of PDAC cells through the regulation of CyclinD1, cyclin-dependent kinase (CDK) 4, CDK6, phospho-signal transducer, activator of transcription 3 (p-STAT3), janus kinase 2 (JAK2), ras homolog gene family member A (RhoA), Rho-associated kinase 1 (ROCK1) and sterile alpha motif domain containing protein 4 (Smad4). The present data suggest that GRP78 plays a crucial role in the proliferation, migration and invasion of pancreatic cancer cells and may be a suitable prognostic marker in PDAC.<\/jats:p>","DOI":"10.1038\/srep16067","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T09:30:24Z","timestamp":1446629424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer"],"prefix":"10.1038","volume":"5","author":[{"given":"Zheyu","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"BFsrep16067_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9\u201329 (2014).","journal-title":"CA Cancer J Clin"},{"key":"BFsrep16067_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jso.23267","volume":"107","author":"ER Witkowski","year":"2013","unstructured":"Witkowski, E. R., Smith, J. K. & Tseng, J. F. Outcomes following resection of pancreatic cancer. J Surg Oncol 107, 97\u2013103 (2013).","journal-title":"J Surg Oncol"},{"key":"BFsrep16067_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent, A., Herman, J., Schulick, R., Hruban, R. H. & Goggins, M. Pancreatic cancer. Lancet 378, 607\u2013620 (2011).","journal-title":"Lancet"},{"key":"BFsrep16067_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/jso.23192","volume":"107","author":"JM Winter","year":"2013","unstructured":"Winter, J. M., Yeo, C. J. & Brody, J. R. Diagnostic, prognostic and predictive biomarkers in pancreatic cancer. J Surg Oncol 107, 15\u201322 (2013).","journal-title":"J Surg Oncol"},{"key":"BFsrep16067_CR5","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1158\/0008-5472.CAN-07-0325","volume":"67","author":"AS Lee","year":"2007","unstructured":"Lee, A. S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67, 3496\u20133499 (2007).","journal-title":"Cancer Res"},{"key":"BFsrep16067_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.4161\/cbt.5.7.2970","volume":"5","author":"Y Fu","year":"2006","unstructured":"Fu, Y. & Lee, A. S. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol Ther 5, 741\u2013744 (2006).","journal-title":"Cancer Biol Ther"},{"key":"BFsrep16067_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/PAI.0b013e3182434113","volume":"20","author":"LW Huang","year":"2012","unstructured":"Huang, L. W., Lin, C. Y., Lee, C. C., Liu, T. Z. & Jeng, C. J. Overexpression of GRP78 is associated with malignant transformation in epithelial ovarian tumors. Appl Immunohistochem Mol Morphol 20, 381\u20133855 (2012).","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"BFsrep16067_CR8","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.ajpath.2011.07.031","volume":"179","author":"A Mozos","year":"2011","unstructured":"Mozos, A. et al. The expression of the endoplasmic reticulum stress sensor BiP\/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma. Am J Pathol 179, 2601\u20132610 (2011).","journal-title":"Am J Pathol"},{"key":"BFsrep16067_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000330883","volume":"87","author":"K Kuroda","year":"2011","unstructured":"Kuroda, K. et al. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma. Urol Int 87, 450\u2013456 (2011).","journal-title":"Urol Int"},{"key":"BFsrep16067_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1447-0756.2012.01970.x","volume":"39","author":"Y Teng","year":"2013","unstructured":"Teng, Y., Ai, Z., Wang, Y., Wang, J. & Luo, L. Proteomic identification of PKM2 and HSPA5 as potential biomarkers for predicting high-risk endometrial carcinoma. J Obstet Gynaecol Res 39, 317\u2013325 (2013).","journal-title":"J Obstet Gynaecol Res"},{"key":"BFsrep16067_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10585-006-9051-9","volume":"23","author":"J Zhang","year":"2006","unstructured":"Zhang, J. et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis 23, 401\u2013410 (2006).","journal-title":"Clin Exp Metastasis"},{"key":"BFsrep16067_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13277-013-1024-4","volume":"35","author":"CT Wu","year":"2014","unstructured":"Wu, C. T. et al. Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression. Tumour Biol 35, 195\u2013204 (2014).","journal-title":"Tumour Biol"},{"key":"BFsrep16067_CR13","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.28137","volume":"133","author":"M Thornton","year":"2013","unstructured":"Thornton, M. et al. The unfolded protein response regulator GRP78 is a novel predictive biomarker in coloretcal cancer. Int J Cancer 133, 1408\u20131418 (2013).","journal-title":"Int J Cancer"},{"key":"BFsrep16067_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0929-6646(10)60060-5","volume":"109","author":"TT Huang","year":"2010","unstructured":"Huang, T. T. et al. Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan. J Formos Med Assoc 109, 326\u2013337 (2010).","journal-title":"J Formos Med Assoc"},{"key":"BFsrep16067_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2407-8-70","volume":"8","author":"R Langer","year":"2008","unstructured":"Langer, R., Feith, M., Siewert, J. R., Wester, H. J. & Hoefler, H. Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. BMC Cancer 8, 70 (2008).","journal-title":"BMC Cancer"},{"key":"BFsrep16067_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/onc.2012.130","volume":"32","author":"B Luo","year":"2013","unstructured":"Luo, B. & Lee, A. S. The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene 32, 805\u201318 (2013).","journal-title":"Oncogene"},{"key":"BFsrep16067_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2407-10-20","volume":"10","author":"R Su","year":"2010","unstructured":"Su, R. et al. Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer 10, 20 (2010).","journal-title":"BMC Cancer"},{"key":"BFsrep16067_CR18","doi-asserted-by":"publisher","first-page":"G1011","DOI":"10.1152\/ajpgi.00466.2013","volume":"306","author":"N Mujumdar","year":"2014","unstructured":"Mujumdar, N. et al. Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol 306, G1011\u201320 (2014).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFsrep16067_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.bpg.2010.02.007","volume":"24","author":"S Raimondi","year":"2010","unstructured":"Raimondi, S., Lowenfels, A. B., Morselli-Labate, A. M., Maisonneuve, P. & Pezzilli, R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence and early detection. Best Pract Res Clin Gastroenterol 24, 349\u2013358 (2010).","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"BFsrep16067_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1053\/j.gastro.2006.10.030","volume":"132","author":"A Shkoda","year":"2007","unstructured":"Shkoda, A. et al. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology 132, 190\u2013207 (2007).","journal-title":"Gastroenterology"},{"key":"BFsrep16067_CR21","doi-asserted-by":"publisher","first-page":"29.e1","DOI":"10.1016\/j.urolonc.2012.10.006","volume":"32","author":"JA Lin","year":"2014","unstructured":"Lin, J. A. et al. Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy. Urol Oncol 32, 29.e1\u201311 (2014).","journal-title":"Urol Oncol"},{"key":"BFsrep16067_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"BFsrep16067_CR23","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0092-8674(00)81519-6","volume":"98","author":"JW Harbour","year":"1999","unstructured":"Harbour, J. W., Luo, R. X., Dei, S. A., Postigo, A. A. & Dean, D. C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859\u2013869 (1999).","journal-title":"Cell"},{"key":"BFsrep16067_CR24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1128\/MCB.18.2.753","volume":"18","author":"AS Lundberg","year":"1998","unstructured":"Lundberg, A. S. & Weinberg, R. A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18, 753\u2013761 (1998).","journal-title":"Mol Cell Biol"},{"key":"BFsrep16067_CR25","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.7314\/APJCP.2013.14.5.2711","volume":"14","author":"V Srivastava","year":"2013","unstructured":"Srivastava, V., Patel, B., Kumar, M., Shukla, M. & Pandey, M. Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder. Asian Pac J Cancer Prev 14, 2711\u20132715 (2013).","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFsrep16067_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/modpathol.2013.125","volume":"27","author":"R Seiler","year":"2014","unstructured":"Seiler, R., Thalmann, G. N., Rotzer, D., Perren, A. & Fleischmann, A. CCND1\/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Mod Pathol 27, 87\u201395 (2014).","journal-title":"Mod Pathol"},{"key":"BFsrep16067_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1746-1596-8-138","volume":"8","author":"S Liang","year":"2013","unstructured":"Liang, S. et al. CyclinD1, a prominent prognostic marker for endometrial diseases. Diagn Pathol 8, 138 (2013).","journal-title":"Diagn Pathol"},{"key":"BFsrep16067_CR28","first-page":"264","volume":"7","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Overexpression of beta-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas. Int J Clin Exp Pathol 7, 264\u2013271 (2014).","journal-title":"Int J Clin Exp Pathol"},{"key":"BFsrep16067_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.surg.2013.05.004","volume":"154","author":"S Yamada","year":"2013","unstructured":"Yamada, S. et al. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery 154, 946\u2013954 (2013).","journal-title":"Surgery"},{"key":"BFsrep16067_CR30","doi-asserted-by":"publisher","first-page":"e107948","DOI":"10.1371\/journal.pone.0107948","volume":"9","author":"Y Kang","year":"2014","unstructured":"Kang, Y. et al. SMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium. PLoS One 9, e107948 (2014).","journal-title":"PLoS One"},{"key":"BFsrep16067_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4161\/sgtp.25131","volume":"4","author":"K O\u2019Connor","year":"2013","unstructured":"O\u2019Connor, K. & Chen, M. Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases 4, 141\u2013147 (2013).","journal-title":"Small GTPases"},{"key":"BFsrep16067_CR32","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/dvdy.20771","volume":"235","author":"AL Tavares","year":"2006","unstructured":"Tavares, A. L., Mercado-Pimentel, M. E., Runyan, R. B. & Kitten, G. T. TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev Dyn 235, 1589\u201398 (2006).","journal-title":"Dev Dyn"},{"key":"BFsrep16067_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/sj.onc.1207003","volume":"23","author":"Y Wu","year":"2004","unstructured":"Wu, Y., Diab, I., Zhang, X., Izmailova, E. S. & Zehner, Z. E. Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89. Oncogene 23, 168\u2013178 (2004).","journal-title":"Oncogene"},{"key":"BFsrep16067_CR34","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.yexcr.2011.05.008","volume":"317","author":"L Raptis","year":"2011","unstructured":"Raptis, L., Arulanandam, R., Geletu, M. & Turkson, J. The R(h)oads to Stat3: Stat3 activation by the Rho GTPases. Exp Cell Res 317, 1787\u20131795 (2011).","journal-title":"Exp Cell Res"},{"key":"BFsrep16067_CR35","doi-asserted-by":"publisher","first-page":"17954","DOI":"10.1074\/jbc.M113.475277","volume":"288","author":"N Balanis","year":"2013","unstructured":"Balanis, N. et al. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J Biol Chem 288, 17954\u201367 (2013).","journal-title":"J Biol Chem"},{"key":"BFsrep16067_CR36","doi-asserted-by":"publisher","first-page":"e95993","DOI":"10.1371\/journal.pone.0095993","volume":"9","author":"LM Judd","year":"2014","unstructured":"Judd, L. M. et al. Inhibition of the JAK2\/STAT3 pathway reduces gastric cancer growth in vitro and in vivo. PLoS One 9, e95993 (2014).","journal-title":"PLoS One"},{"key":"BFsrep16067_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/neuonc\/nos302","volume":"15","author":"OD Stechishin","year":"2013","unstructured":"Stechishin, O. D. et al. On-target JAK2\/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells. Neuro Oncol 15, 198\u2013207 (2013).","journal-title":"Neuro Oncol"},{"key":"BFsrep16067_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11060-010-0273-y","volume":"101","author":"C Senft","year":"2011","unstructured":"Senft, C. et al. Inhibition of the JAK-2\/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101, 393\u2013403 (2011).","journal-title":"J Neurooncol"},{"key":"BFsrep16067_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/1535-7163.MCT-12-0809","volume":"12","author":"K Guo","year":"2013","unstructured":"Guo, K. et al. Interaction of the sympathetic nerve with pancreatic cancer cells promotes perineural invasion through the activation of STAT3 signaling. Mol Cancer Ther 12, 264\u2013273 (2013).","journal-title":"Mol Cancer Ther"},{"key":"BFsrep16067_CR40","doi-asserted-by":"publisher","first-page":"e25941","DOI":"10.1371\/journal.pone.0025941","volume":"6","author":"H Li","year":"2011","unstructured":"Li, H. et al. STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice. PLoS One 6, e25941 (2011).","journal-title":"PLoS One"},{"key":"BFsrep16067_CR41","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1111\/j.1582-4934.2009.00873.x","volume":"13","author":"J Wang","year":"2009","unstructured":"Wang, J. et al. Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response. J Cell Mol Med 13, 3888\u20133897 (2009).","journal-title":"J Cell Mol Med"},{"key":"BFsrep16067_CR42","first-page":"883","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation and cancer. Cell 140, 883\u2013899 (2010).","journal-title":"cancer. Cell"},{"key":"BFsrep16067_CR43","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1158\/0008-5472.CAN-08-2689","volume":"69","author":"S Saito","year":"2009","unstructured":"Saito, S. et al. Chemical genomics identifies the unfolded protein response as a target for seletcive cancer cell killing during glucose deprivation. Cancer Res 69, 4225\u20134234 (2009).","journal-title":"Cancer Res"},{"key":"BFsrep16067_CR44","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1593\/neo.09878","volume":"11","author":"JM Backer","year":"2009","unstructured":"Backer, J. M. et al. Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells. Neoplasia 11, 1165\u20131173 (2009).","journal-title":"Neoplasia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep16067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16067","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:33:16Z","timestamp":1672925596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep16067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]}},"alternative-id":["BFsrep16067"],"URL":"https:\/\/doi.org\/10.1038\/srep16067","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]},"assertion":[{"value":"10 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16067"}}